Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
US10717775B2 · kind B2 · utility
0Cited by
21References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 29, 2018 |
| Grant date | Jul 21, 2020 |
| Priority date | — |
| Expiry date | Aug 29, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods of treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.